Clinical Diagnostics Recombinant protein advancements revolutionize assay developmentToni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research
Life Sciences Enhance productivity and purity in next-generation bispecific antibody manufacturing Jul 14, 2025
Life Sciences Enhance productivity and purity in next-generation bispecific antibody manufacturing Jul 14, 2025
Clinical Diagnostics A game-changing approach to infection control at the University Hospital Heidelberg
Drug discovery > Clinical Development HotSpot Therapeutics presents preclinical data from the CARD11-BCL10-MALT1 (CBM) signalosome program
Life Sciences Bio-Rad expands Droplet Digital PCR offering through strategic acquisition and platform rollout
Drug Discovery & Development HORIBA opens new Analytical Solution Plaza to support UK science and research